ELAN Stock Elanco Animal Health Incorporated
US · NYSELast in our picks 2026-10-08 — not in the current list; analysis below is from that screen
Pet-health demand and operational improvements offer cyclical earnings recovery potential.
Future value: $31.00 (+38.64%) · 6-12 months · analyst consensus
Signal breakdown
- ▸New-product launches and margin recovery are key upcoming catalysts.
- ▾Below 50-day MA (-5.2%)
- ▸~39% upside to price target
Is ELAN a buy right now?
Trend: ELAN is trading below the 50-day average (-2.97%), RSI 50 — neutral momentum, with a 3-month return of -11.37%.
Valuation & quality: Elanco Animal Health Incorporated trades on forward P/E 17.8, PEG 4.04, price-to-book 1.74; fundamentals show net margin -4.0%, return on equity -3.0%, revenue growth 10.2% year on year.
Analyst consensus: 13 analysts have a mean 12-month price target of $30.31 (+32% vs the last close; range $24.00 – $34.00), consensus rating “buy”.
Our screen: ACCUMULATE (score 1) — Pet-health demand and operational improvements offer cyclical earnings recovery potential.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -9.40% | -6.50% | +6.60% | +3.20% | +7.20% | -9.30% | -6.40% | +0.60% |
Fundamentals
Analyst price target
Technical signals
About Elanco Animal Health Incorporated
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic · United States · 9,400 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.